mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.

CONCLUSION: Specific combinations of CSC markers and β-catenin/mTOR signaling could be a significant predictor of poor survival in stage II CRC.
PMID: 32608200 [PubMed - in process]

Source: Yonsei Medical Journal - June 30, 2020 Category: Universities & Medical Training Authors: Chang JY, Kim JH, Kang J, Park Y, Park SJ, Cheon JH, Kim WH, Kim H, Park JJ, Kim TI Tags: Yonsei Med J Source Type: research